Rick A. Bright, PhD

Director, Biomedical Advanced Research and Development Authority
Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS)

Rick Bright, Ph.D., is director of the Biomedical Advanced Research and Development Authority (BARDA) and acting Deputy Assistant Secretary in the Office of the Assistant Secretary for Preparedness and Response within HHS. BARDA develops and provides medical countermeasures to man-made and natural threats including chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseases. BARDA meets this mission by supporting product innovation, advanced development, acquisition and stockpiling, and building manufacturing infrastructure.

Dr. Bright previously served as Director of the Influenza and Emerging Infectious Diseases Division in the BARDA where he was responsible for preparing the nation for influenza pandemics and coordinating production, acquisition and delivery of medical countermeasures during a pandemic response.

Dr. Bright has also worked in the biotechnology industry where he served as the Director of Immunology at Altea Therapeutics and Vice President of Research and Development and Global Influenza Programs at Novavax, Inc. In 2008, Dr. Bright joined PATH as the Scientific Director of the Influenza Vaccine Project in the Vaccine Development Global Program and the Director of the Influenza Vaccine Capacity Building Project in Vietnam. In this capacity, he provided technical leadership to accelerate the development of innovative vaccine and adjuvant candidates against influenza to ensure protection and access to vaccines for populations of developing countries.

Dr. Bright received his PhD in Immunology and Molecular Pathogenesis from Emory University (Atlanta, GA) and his BS in Biology (Medical Technology) and Physical Sciences from Auburn University (Montgomery, AL).

Presentation(s):

    Send Email for Rick Bright